PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3080291-9	1986	Misoprostol 400 micrograms bid was superior to placebo (P = 0.002) in healing ulcers.	Misoprostol	0-11	BH3 interacting domain death agonist	Homo sapiens	27-30	
1962619-11	1991	In conclusion, the adverse events in the misoprostol 200 micrograms bid group were not significantly different from those in the placebo group, and were significantly better than in the misoprostol 200 micrograms qid group.	Misoprostol	41-52	BH3 interacting domain death agonist	Homo sapiens	68-71	
3080291-10	1986	However, the healing rate for misoprostol 200 micrograms bid did not differ significantly from placebo.	Misoprostol	30-41	BH3 interacting domain death agonist	Homo sapiens	57-60